Trial
NCT07684586
A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Cough
Intervention
Camlipixant
Why stopped
The study has been suspended given the recent decision to cease further development of camlipixant in RCC based on Phase 3 program results.
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-24